The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement
Salman Otoukesh, Jianying Zhang, Ryotaro Nakamura, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat, Ibrahim Aldoss
Abstract
To the EditorExtramedullary disease (EMD) is not an uncommon presentation at the time of acute myeloid leukemia (AML) diagnosis and/or relapse, and can present either as an isolated disease (myeloi...
Topics & Concepts
VenetoclaxMedicineMyeloid leukemiaHypomethylating agentLeukemiaMyeloidCancer researchOncologyImmunologyBiologyGeneDNA methylationGeneticsChronic lymphocytic leukemiaGene expressionAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentRetinoids in leukemia and cellular processes